Pharmaceutical Quality Control Release Testing Service Market Size Projected To Increase From $8.13 Billion To $11.01 Billion During The Forecast Period
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Pharmaceutical Quality Control Release Testing Service Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The pharmaceutical quality control release testing service market has witnessed substantial growth over recent years. It is anticipated to expand from $7.55 billion in 2025 to $8.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the past can be attributed to more rigorous GMP regulations, a surge in global drug manufacturing, an increase in contract testing laboratories, rising requirements for biologics testing, and the broadened production of generic drugs.
The pharmaceutical quality control release testing service market size is projected to experience substantial expansion in the coming years. Its valuation is set to reach $11.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This anticipated expansion throughout the forecast period stems from factors such as the increasing development of complex biologic pipelines, a heightened frequency of regulatory audits, the wider adoption of outsourced QC models, a growing need for quicker batch release cycles, and an increase in multi-region drug approvals. Notable trends expected during this period encompass automated batch release testing, the implementation of digital laboratory quality systems, AI-assisted analytical validation, the emergence of connected stability testing labs, and the deployment of smart quality data platforms.
Download A Free Sample Report For Comprehensive Market Insights:
Pharmaceutical Quality Control Release Testing Service Market Industry Drivers: What Is Driving Revenue Growth?
The increasing number of cell or gene therapy pipelines is anticipated to drive the advancement of the pharmaceutical quality control release testing service market moving forward. These pipelines consist of cellular and genetic therapeutic products currently undergoing development and regulatory assessment for eventual commercialization. This growth is predominantly fueled by heightened investment in biotechnology research and development, as pharmaceutical companies and biotech firms allocate substantial resources towards innovative cellular and genetic treatments for conditions previously considered untreatable. A burgeoning cell and gene therapy pipeline directly boosts the requirement for specialized quality control release testing services, which are vital for ensuring these complex biological products meet rigorous safety and efficacy standards prior to their market launch. For instance, in January 2025, data from the American Society of Gene and Cell Therapy, a US-based scientific association, indicated that the global gene therapy pipeline reached 2,117 programs in the fourth quarter of 2024, up from 2,041 programs in the third quarter of 2024. Hence, the expansion of cell or gene therapy pipelines is a significant force behind the growth of the pharmaceutical quality control release testing service market.
Pharmaceutical Quality Control Release Testing Service Market Categorization By Product Type And Application
The pharmaceutical quality control release testing service market covered in this report is segmented –
1) By Product Type: Dissolution Testing; Anti-Corrosion Testing; ICH Stability Storage and Testing; Other Product Types
2) By Service Type: Analytical Testing Services; Microbiological Testing Services; Stability Testing Services; Sterility Testing Services
3) By Technology: Gas Chromatography (GC); Mass Spectrometry; Spectroscopy Methods
4) By End Users: Pharmaceutical Manufacturers; Biotechnology Companies; Contract Development and Manufacturing Organizations (CDMOs); Contract Manufacturing Organizations (CMOs); Research and Academic Institutions
Subsegments:
1) By Dissolution Testing: Immediate Release Testing; Extended Release Testing; Delayed Release Testing; Sink Condition Evaluation
2) By Anti-Corrosion Testing: Packaging Material Corrosion Testing; Container Compatibility Assessment; Environmental Stress Corrosion Testing; Protective Coating Evaluation
3) By ICH Stability Storage and Testing: Long Term Stability Studies; Accelerated Stability Studies; Intermediate Stability Studies; Photostability Testing
4) By Other Product Types: Impurity Profiling; Residual Solvent Testing; Elemental Impurity Analysis; Container Closure Integrity Testing
#Pharmaceutical Quality Control Release Testing Service Market Growth Trends: What Is Influencing The Future Outlook?
Major companies in the pharmaceutical quality control release testing services market are focusing on developing advanced solutions, such as microbiological quality control testing, to ensure product sterility, regulatory compliance, and timely batch release. This microbiological quality control testing utilizes specific techniques to monitor and measure microbial presence in pharmaceutical products and production settings, which assists in confirming sterility, maintaining product safety, and meeting regulatory requirements before batch release. For instance, in March 2025, Nelson Laboratories, a US-based microbiological testing company, introduced its Rapid Sterility Testing, a microbiology-based quality control testing offering designed to modernize sterility assurance processes. This solution is engineered to support faster batch release of sterile pharmaceutical products, shortening traditional fourteen-day incubation timelines to approximately six days. It also incorporates automated, quantitative data analytics to enhance result precision, reduce manual intervention, and improve overall testing reliability.
Pharmaceutical Quality Control Release Testing Service Market Company Landscape And Strategic Competition
Major companies operating in the pharmaceutical quality control release testing service market are Labcorp Holdings Inc., SGS S.A., Eurofins Scientific SE, Selvita S.A., WuXi AppTec Co. Ltd., Intertek Group plc, Charles River Laboratories International Inc., Piramal Pharma Limited, Siegfried Holding AG, Almac Group Limited, NSF International, ClinChoice Inc., BioAgilytix Inc., Microbac Laboratories Inc., ARL Bio Pharma Inc., Quality Chemical Laboratories LLC, Neopharm Labs Inc., Butterworth Laboratories Limited, Cambridge Polymer Group Inc., Honeyman Group Limited, and Element Materials Technology Group Limited.
Access The Complete Pharmaceutical Quality Control Release Testing Service Market Report:
Pharmaceutical Quality Control Release Testing Service Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the pharmaceutical quality control release testing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical quality control release testing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
